Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Temple Researchers Take a Leading Role in Medical Marijuana Studies

View All News

The Philadelphia Inquirer published a story featuring the cannabinoid research being led by Sara Jane Ward, PhD, Assistant Professor of Pharmacology at the Lewis Katz School of Medicine at Temple University; and Ronald Tuma, PhD, G.H. Stewart Professor of Physiology, Professor of Neurosurgery and Professor in the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University.